Atlas Trials

Bioequivalence Study: 2 mg Estradiol Valerate (EV) and 3 mg Dienogest (DNG) Without and With Levomefolate Calcium

Clinical trial NCT00941057 · COMPLETED

Trial details

NCT number
NCT00941057
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pharmacology, Clinical
Start date
2009-09-01
Primary completion
2009-12-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.